Discover the Phase I study of the dual-function autologous FANG vaccine, a novel approach in advanced cancer treatment.

TRANSLATIONAL PHASE I STUDY IN ADVANCED CANCER PATIENTS OF DUAL-FUNCTION AUTOLOGOUS (FANG) VACCINE INCORPORATING BIFUNCTIONAL SHRNAFURIN AND GMCSF TRANSGENE EXPRESSION

Monday, July 26, 2010